Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 14 min ago
Peer-reviewedCC BY-NC-ND 4.0Scientific Reports

Cell-type and donor-level epigenetic variation shape intestinal inflammatory responses to SARS-CoV-2 spike protein

Abstract

Although coronavirus disease 2019 (COVID-19) is associated with gastrointestinal symptoms and systemic hyperinflammation, the epigenetic mechanisms linking SARS-CoV-2 to intestinal immune activation remain poorly understood. We investigated histone modifications in human ileum immune cells following ex vivo exposure to the recombinant SARS-CoV-2 spike protein using mass cytometry. Cytokine expression (TNF-α, IFN-γ, IL-17A, IL-6, and IL-10) and 14 histone marks were evaluated across eight major immune cell subsets, including B cells, T cells, resident T cells, natural killer (NK) cells, NKT cells, γδ T cells, mucosal-associated invariant T (MAIT) cells, and macrophages (MФ). Spike protein exposure induced coordinated inflammatory cytokine responses accompanied by extensive cell-type-specific epigenetic remodeling. MAIT cells, resident T cells, conventional T cells, and MФ exhibited the greatest chromatin remodeling. In contrast, NK cells, NKT cells, B cells, and γδ T cells showed no or few significant epigenetic changes. Linear mixed-effects modeling indicated that epigenetic associations with inflammatory responses were primarily attributable to differences between donors rather than variation among cell subsets within the same donor. Cell-subset identity remained independently associated with inflammatory response, with resident T cells showing significantly higher inflammatory scores, while the other cell subsets did not differ significantly. Together, these findings suggest that interindividual epigenetic variation and cell-subset identity are key determinants of intestinal inflammatory responses to SARS-CoV-2 spike protein.

Related

  1. Epigenetic demethylation sensitizes cancer cells to CAR-M triggered pyroptosis and remodels inflammatory immune responses in the tumor microenvironment to potentiate CAR-M cell therapy
    Wenhui Chu, Yuanhui Xu, Liting Lin +11
    Journal for Immunotherapy of CancerPeer-reviewedCC BY-NC 4.0Full textOncologyPMC
  2. Methylation profiling reveals epigenetic programs associated with chr18 loss in small intestinal neuroendocrine tumors
    Fredrik Axling, Samuel Backman, Per Hellman +2
    Frontiers in oncologyPeer-reviewedCC BYFull textEpidemiology & public healthEurope PMCCrossref
  3. From microbial dysbiosis to putative epigenetic locking: a hypothesis-driven framework for the pathogenesis and future therapeutic perspectives of gastric intestinal metaplasia.
    Yingyue Sheng, Chaosheng Yan, Yuzhe Yin +6
    Journal of translational medicinePeer-reviewedCC BY-NC-NDFull textSurgery & anaesthesiaEurope PMCPMC
  4. La gran simuladora: tres casos de enfermedad inflamatoria intestinal asociada a errores innatos de la inmunidad The Great Imposter: Three Cases of Inflammatory Bowel Disease Associated with Innate Immune Defects
    Diana Paola Sánchez Hernández, Sara Vallejo Tamayo
    Acta gastroenterologica LatinoamericanaPeer-reviewedCC BY-NC-SAFull textGeneral medicineEurope PMC
  5. Selective Dopamine Transporter Inhibitor CE-123 Modulates Region-Specific Intestinal Mucosal and Immune Responses Following Fear Conditioning and Extinction in Adolescent Female Rats
    Katarzyna Kras, Małgorzata Manastyrska-Stolarczyk, Kamil Arciszewski +6
    BiomedicinesPeer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{chen2026celltype,
  title = {{Cell-type and donor-level epigenetic variation shape intestinal inflammatory responses to SARS-CoV-2 spike protein}},
  author = {H. Chen and J. Bailey and E. Mezghanni and M. B. Sztein and A. C. Bafford and R. Salerno-Goncalves},
  journal = {Scientific Reports},
  year = {2026},
  month = oct,
  doi = {10.1038/s41598-026-72904-1},
  url = {https://www.nature.com/articles/s41598-026-72904-1},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Cell-type and donor-level epigenetic variation shape intestinal inflammatory responses to SARS-CoV-2 spike protein
AU  - H. Chen
AU  - J. Bailey
AU  - E. Mezghanni
AU  - M. B. Sztein
AU  - A. C. Bafford
AU  - R. Salerno-Goncalves
PY  - 2026
DA  - 2026/10/21
JO  - Scientific Reports
DO  - 10.1038/s41598-026-72904-1
UR  - https://www.nature.com/articles/s41598-026-72904-1
AB  - Although coronavirus disease 2019 (COVID-19) is associated with gastrointestinal symptoms and systemic hyperinflammation, the epigenetic mechanisms linking SARS-CoV-2 to intestinal immune activation remain poorly understood. We investigated histone modifications in human ileum immune cells following ex vivo exposure to the recombinant SARS-CoV-2 spike protein using mass cytometry. Cytokine expression (TNF-α, IFN-γ, IL-17A, IL-6, and IL-10) and 14 histone marks were evaluated across eight major immune cell subsets, including B cells, T cells, resident T cells, natural killer (NK) cells, NKT cells, γδ T cells, mucosal-associated invariant T (MAIT) cells, and macrophages (MФ). Spike protein exposure induced coordinated inflammatory cytokine responses accompanied by extensive cell-type-specific epigenetic remodeling. MAIT cells, resident T cells, conventional T cells, and MФ exhibited the greatest chromatin remodeling. In contrast, NK cells, NKT cells, B cells, and γδ T cells showed no or few significant epigenetic changes. Linear mixed-effects modeling indicated that epigenetic associations with inflammatory responses were primarily attributable to differences between donors rather than variation among cell subsets within the same donor. Cell-subset identity remained independently associated with inflammatory response, with resident T cells showing significantly higher inflammatory scores, while the other cell subsets did not differ significantly. Together, these findings suggest that interindividual epigenetic variation and cell-subset identity are key determinants of intestinal inflammatory responses to SARS-CoV-2 spike protein.
SN  - 2045-2322
ER  -